SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-103220
Filing Date
2023-09-22
Accepted
2023-09-22 16:40:19
Documents
5
Period of Report
2023-10-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2326633d1_pre14a.htm PRE 14A 195953
2 GRAPHIC tm2326633d1_pre14a-img01.jpg GRAPHIC 485676
3 GRAPHIC tm2326633d1_pre14a-img02.jpg GRAPHIC 545861
4 GRAPHIC tm2326633d1_pre14a-img03.jpg GRAPHIC 513560
5 GRAPHIC tm2326633d1_pre14a-img04.jpg GRAPHIC 526243
  Complete submission text file 0001104659-23-103220.txt   3050629
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36598 | Film No.: 231272207
SIC: 2834 Pharmaceutical Preparations